FDA investigates the reports of infections associated with reprocessed urological endoscope

▴
The FDA puts its best foot forward to ensure safety in regard to reprocessed medical devices. The FDA is actively engaged to help understand the risk and the causes associated with endoscopic procedures.

Endoscopic Superbugs infections 

Doctors use an endoscope to look inside the patient’s body to screen for disease and in some cases treat existing conditions. Endoscopic devices consist of light video cameras attached to long thin plastic tubes. Certain endoscopes come under scrutiny for potentially spreading the carbapenem-resistant Enterobacteria - a potentially deadly antibiotic resistant infection even when proper disinfection procedures are followed. 

According to FDA, duodenoscopes, a type of endoscope used for endoscopic retrograde cholangiopancreatography (ERCP) procedures to examine the GIT system especially the pancreatic and bile ducts are designed in a way that may prevent the full cleaning and disinfection. If you have come across anyone who has unexplained illness after an endoscopic procedure, there are higher chances of infection. 

Sterilizing endoscopic devices are important 

Sterilizing the duodenoscopes between the uses requires hospital personnel to pay detailed attention to it. It is important for the safety of the patients to sterilize and disinfect the endoscopic medical devices and instruments regularly after each use. A multi-step process and detailed thorough cleaning and disinfection is a must to eliminate the risk and reduce the risk of transmitting serious infections. These infections can cause life-threatening conditions between the uses. The Center for Disease Control and Prevention (CDC) has reported the potential link between the multidrug-resistant bacterial infections in patients who have undergone endoscopic procedures with the reprocessed medical devices or instruments. 

FDA announcements regarding the Reprocessed endoscopic devices

The FDA announced that it is investigating numerous medical devices causing patient infection and other possible contamination issues due to the reuse. The reprocessed urological endoscopic devices like cystoscope, ureteroscope, and cystourethroscopy devices which are needed to view the urinary tract and system have higher chances of spreading infection among the patients exposed to endoscopy.

Reprocessing of the medical devices involves both cleaning, disinfection, and sterilization of the devices and instruments before reuse. Medical devices are supposed to improve your care and not put you at risk of potentially fatal infection. If anyone has contracted the infection due to the endoscopic procedure, it is important to bring it to light. Proper guidance must be given to the hospital personnel to take further action to prevent these types of infection which can spread through the contamination of medical devices. 

FDA action incase of reprocessing of medical devices 

From Jan 1 2017 to Feb 20, 2021, the FDA received over 450 Medical Devices Reprocessed describing post-procedure patient infections or other possible contamination issues associated with reprocessing these devices. Many medical device companies were cited in the FDA's reports. The FDA is continuing to investigate these reports, but the FDA has not concluded any specific manufacturer or brand of devices to be associated with a higher risk of contamination. 

The letter to health care providers, hospitals, and medical professionals on April 1, 2021, provides recommendations of reprocessing and using the devices as per the instructions laid by the FDA. It is important to discuss and know the potential risk and benefits associated with the procedures involving reprocessed urological endoscopes with patients. 

Tags : #FDA #medicaldevices #endoscope #bacterialinfection #medicircle #myhealth

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026